Other authors have also identified a correlation between high levels of CD44 expression and various adverse outcomes in patients with HNSCC, including cancer recurrence,29,30 poor response to radiotherapy,31 regional metastasis,32 and reduced overall survival.10 The gene discussed is CD44; the disease is head and neck squamous cell carcinoma.